This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Fernando Alarcón, MD
Department of Neurology Eugenio Espejo Hospital Casilla 8991, Sucursal 7 Quito, Ecuador

Arch Neurol. 1990;47(12):1278-1279.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

In Reply.

—The short course of treatment for neurocysticercosis with albendazole¹ was based on the following observations: the adverse reactions to praziquantel or to albendazole occur only during the first days of the antiparasitic treatment^2,3; these reactions have been interpreted as predictors of a favorable therapeutic outcome, since they are secondary to the destruction of the parasites.^2-4 In an unpublished study that was carried out in our department, prior to carrying out the shortened course of treatment,¹ we found that, among the 20 patients with neurocysticercosis who were administered albendazole for 30 days,² the adverse reactions occurred between the second and third days after treatment was initiated in 65% of the cases (13/20), and remission in these patients occurred at the end of the first week with the aid of symptomatic drugs, as other studies have reported^2,5; in this unpublished study with 20 . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?